FSU research team makes Zika drug breakthrough
news.fsu.edu
news.fsu.edu
>"The screening of two subsets of compounds for antiviral activity (Supplementary Fig. 2a and Supplementary Fig. 4b) was performed in a blinded manner, whereas all other experiments were performed in a nonblinded manner." http://www.nature.com/nm/index.html
Also, I searched for the virus strain they used and the first thing I clicked on claimed it has issues with relevance in vivo:
>"Anyone who is using viruses termed ZIKV MR766 needs to carefully examine the sequence composition of their stocks. Multiple viruses all termed MR766 may have different sequences and biological properties.In the case of the MR766 we are using in our studies, there is a deletion in the challenge stock that is strongly selected against quickly in vivo." https://zika.labkey.com/wiki/OConnor/ZIKV-002/page.view?name...
Nicolsamide is also listed as WHO's "one of the most important medications needed in a basic health system."[1]
There should be more drug repurposing researches to be done but it's probably profit-prohibiting for the big pharmas :(
I don't necessarily agree with the snark but we'd probably be better off if more medical research were not profit-motivated.
That's not entirely true. There are programs in the US and UK which offer "marketing exclusivity" for companies that perform trials validating new uses for existing drugs. These aren't exactly patents, but it does provide a financial incentive.
http://www.fsu.edu/highlights/rankings.html has some interesting tidbits on our rankings.
... Yes, I recall correctly. Myron Rolle. Played two years in the NFL then returned to FSU medical school.
Of course, I'm from UF....so maybe I should be agreeing with you ;)
also really liked the search strategy. first try all the things already approved by the fda to find something, even if not 100% ideal since its so much faster than seeking fda approval of something new. Curious how this will change in the near future given the prevalence of deep learning and with some of the opentrons type testing systems.
Yup. On the one hand it's unfortunate that they have to do this at all, on the other hand this may be a larger innovation than the Zika treatments themselves.
In the long run if this approach can be applied to other diseases it'll save many lives.